Hassle-Free Site Selection and Study Start-up for Clinical Trials in Canada
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
It is no secret that Canada’s presence as a key player in the field of pharmaceutical drug development is rapidly…
Myths exist to explain things we don’t understand, as well as to continue traditions and keep relationships and societies ‘safe’.…
6 Critical Factors for Prevention & Mitigation Collecting clinical data that are accurate, reliable and of high quality is the…
Developing oncology compounds is a constantly evolving process, and with the dramatic rise in costs, and competitive trials, making every…
CRAs with Key Soft Skills Leads to Honest Communication and Better Risk Management at Sites Open communication with sites is…
The daffodil is a symbol of strength, of resilience, of courage and life. It survives our harsh Canadian winters to…
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…
What’s in Store for 2019 and Beyond? The Clinical Trials Market was valued at USD 32,700 million in 2017 and…
7 Tips for efficient study start-up: No.1) Involve Canadian oncologists early on and gather country-specific insight regarding possible enrollment…
Each clinical study presents unique challenges, and it’s not unusual despite every effort that a clinical trial does not proceed…